No price history available.
Key financial summary
Financials in AUD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | AUDm | 968 | 928 | 1,049 | 1,260 | 1,263 | 1,303 | N/A | N/A |
| Operating profit | AUDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | AUDm | -9 | 25 | 42 | 42 | 40 | 43 | N/A | N/A |
| EPS reported | AUD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | AUD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | AUD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | AUD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | AUDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | AUDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | AUDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | AUD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | AUD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in AUD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Ridley Corporation Limited, an Australian enterprise, specializes in offering extensive animal nutrition solutions. Its operations are divided into two main segments: Packaged Feeds and Ingredients, and Bulk Stockfeeds. The company provides a diverse range of packaged products and dietary supplements, including various bagged feeds for poultry, dairy, dogs, horses, and other domestic animals, alongside block and loose lick supplements. Ridley also manufactures aquafeed, encompassing extruded and steam-pelleted options tailored for different fin fish and prawns. Furthermore, it processes poultry, red meat, and fish to create rendered products utilized in the pet food, stockfeed, and aquaculture industries. The company's offerings extend to specialized monogastric and ruminant feeds, such as pellets, meals, concentrates, and premixes, designed for poultry, pigs, dairy and beef cattle, and sheep. Beyond product manufacturing, Ridley delivers expert nutritional guidance to food producers across the dairy, poultry, pig, aquaculture, sheep, and beef sectors, supplies the research community with solutions for laboratory animals, and caters to retail markets for equine, canine, and home layer animals. Key brands under its umbrella include Barastoc, Rumevite, Cobber, Primo, and Food for Dogs. Founded in 1987 and headquartered in Melbourne, Australia, Ridley Corporation Limited also engages in international export activities.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Ridley Corporation Limited (RIC.AX)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Ridley Corporation Limited, an Australian enterprise, specializes in offering extensive animal nutrition solutions. Its operations are divided into two main segments: Packaged Feeds and Ingredients, and Bulk Stockfeeds. The company provides a diverse range of packaged products and dietary supplements, including various bagged feeds for poultry, dairy, dogs, horses, and other domestic animals, alongside block and loose lick supplements. Ridley also manufactures aquafeed, encompassing extruded and steam-pelleted options tailored for different fin fish and prawns. Furthermore, it processes poultry, red meat, and fish to create rendered products utilized in the pet food, stockfeed, and aquaculture industries. The company's offerings extend to specialized monogastric and ruminant feeds, such as pellets, meals, concentrates, and premixes, designed for poultry, pigs, dairy and beef cattle, and sheep. Beyond product manufacturing, Ridley delivers expert nutritional guidance to food producers across the dairy, poultry, pig, aquaculture, sheep, and beef sectors, supplies the research community with solutions for laboratory animals, and caters to retail markets for equine, canine, and home layer animals. Key brands under its umbrella include Barastoc, Rumevite, Cobber, Primo, and Food for Dogs. Founded in 1987 and headquartered in Melbourne, Australia, Ridley Corporation Limited also engages in international export activities.
